SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is trending amid a sharp sell-off that pushed shares to multi-year lows, driven by mounting investor skepticism over the effectiveness of the company's turnaround initiatives and intensifying competition. The community remains deeply polarized, with some traders hunting for a value-play bounce due to dividend yields, while others are aggressively shorting the stock, citing poor brand sentiment and long-term fundamental decline.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology Group Inc. is trending as investors debate the impact of potential earnings catalysts and concerns surrounding convertible debt. Community discussion is heavily divided between bulls anticipating an explosive upside from upcoming financial results and infrastructure projects, and bears highlighting historical dilution and lack of transparency regarding earnings scheduling.

Fabrinet engages in the provision of optical packaging and electronic manufacturing services to original equipment manufacturers. The firm's engineering services include process design, failure analysis, reliability testing, tooling design, and real-time traceability system. Its manufacturing operations offer sensors, subsystems, customized optics, and optical modules and components. The company was founded by David Thomas Mitchell on August 12, 1999 and is headquartered in George Town, Cayman Islands.

Fabrinet

Fabrinet is currently drawing attention from investors following a strong earnings report that included both revenue and EPS beats, alongside an upward revision to full-year revenue guidance. While the stock initially surged, it has faced volatility as market participants debate the balance between robust AI-driven optical demand and underlying pressures on free cash flow and operational margins.

Duos Technologies Group, Inc. designs, develops, deploys, and operates intelligent technology solutions supporting rail, logistics, intermodal and government customers that streamlines operations, improves safety and reduces costs. It offers imaging, safety and security, software, and services. The firm also provides cutting edge solutions that automate the mechanical and security inspection of fast moving trains, trucks and automobiles through a broad range of proprietary hardware, software, information technology and artificial intelligence. The company was founded on May 31, 1994 and is headquartered in Jacksonville, FL.

Duos Technologies Group Inc

Duos Technologies is capturing market interest as investors monitor its aggressive AI data center expansion, highlighted by a significant $500 million hosting agreement with Axe Compute. The community is actively debating the company's ability to scale infrastructure rapidly, while weighing the potential for sustained revenue growth against concerns regarding future capital requirements.

lululemon athletica, Inc. engages in the business of designing, distributing, and retailing technical athletic apparel, footwear, and accessories. It operates through the following segments: Company-Operated Stores, Direct to Consumer, and Other. The company was founded by Dennis James Wilson in 1998 and is headquartered in Vancouver, Canada.

Lululemon Athletica inc.

Lululemon Athletica Inc

Lululemon is under intense market pressure amid executive departures and concerns over product quality, with investors debating whether the stock is a deep-value turnaround play or a struggling brand losing ground to competitors. While some traders are betting on a squeeze fueled by institutional accumulation and the upcoming arrival of a new CEO, others remain skeptical, pointing to weak retail trends and a shifting consumer landscape.

Kura Oncology, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the research and development of medicines for the treatment of cancer. Its pipeline includes Tipifarnib, which is a Farnesyl transferase inhibitor for HRAS Mutant Solid Tumors, Chronic Myelomonocytic Leukemia, KO-947, which is an ERK inhibitor for MAPK Pathway Tumors, and KO-539, which is a Menin MLL inhibitor for acute leukemias. The company was founded by Troy E. Wilson, Yi Liu, Pingda Ren and Antonio Gualberto on August 22, 2014 and is headquartered in San Diego, CA.

Kura Oncology Inc

Kura Oncology is trending following the FDA approval of KOMZIFTI, with community sentiment shifting toward its competitive advantage as a once-daily, best-in-class menin inhibitor for relapsed or refractory AML. Investors are actively discussing the company's strong cash position and milestone payments while debating the potential for a near-term buyout and the upcoming data readouts at ASH as key indicators for its frontline expansion potential.

Netlist, Inc. engages in the design, manufacture and sale of memory subsystems for the computing and communications markets. Its products include enterprise SSD, embedded flash, memory module, lightning DDR5 DIMM, SK hynix, AI server. The company was founded by Jayesh Bhakta, Chun Ki Hong and Christopher Lopes in June 2000 and is headquartered in Irvine, CA.

Netlist Inc

Netlist is trending as investors digest the recent Samsung settlement and brace for upcoming legal catalysts, including the September 9 oral hearing against Micron. Community discussion is heavily focused on the potential for further licensing deals, the impact of new ITC litigation against major industry players, and the ongoing debate over whether the stock's recent momentum is sustainable.

Amylyx Pharmaceuticals, Inc. is a biotechnology company focused on the discovery and development of therapies for diseases with significant unmet medical need, with an emphasis on endocrine and neurodegenerative disorders. Its program, avexitide, is a once-daily GLP-1 receptor antagonist being developed for the treatment of post-bariatric hypoglycemia. Amylyx’s pipeline also includes investigational programs targeting Wolfram syndrome and amyotrophic lateral sclerosis (ALS). The company was founded by Joshua Cohen and Justin Klee in 2013 and is headquartered in Cambridge, MA.

Amylyx Pharmaceuticals Inc

Amylyx Pharmaceuticals is trending as the community eagerly anticipates Phase 3 LUCIDITY topline results for avexitide in post-bariatric hypoglycemia. Investors are closely monitoring the upcoming data release, with many discussions centering on the company's strong cash runway and optimistic price target revisions from analysts.

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

Ocular Therapeutix is trending due to the anticipation of an upcoming investor day, with the market focused on potential clarity regarding the company's NDA submission strategy and overall commercialization path. Community discussion is heavily centered on the ongoing debate over the drug's competitive position and a potential buyout, as traders closely monitor high short interest and institutional accumulation.

Aurora Innovation, Inc. engages in the design and development of automobile hardware, software, and provision of data services. It offers the Aurora Driver which allows a vehicle to drive itself. The company was founded by Christopher Urmson, Sterling Anderson and James Andrew Bagnell in 2017 and is headquartered in Pittsburgh, PA.

Aurora Innovation Inc - Ordinary Shares - Class A

Aurora Innovation is trending as the market reacts to the successful launch of its second-generation driverless truck fleet and anticipation surrounding an upcoming livestream demonstration of the technology. Community sentiment is largely bullish, with investors actively discussing potential large-scale commercial partnerships and the company's progress toward scaling production to meet high demand despite ongoing macroeconomic headwinds.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


damangamesplus

damangames plus